docs (beta)

42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen 
=== VARIABELEN ===
Array
(
    [defid] => VWS-WOO-08-1083813
    [request_id] => 
)

=== SQL LOG ===
Geen SQL queries.
Huidig document record 
Array
(
    [id] => e3f3badb-e662-4c6f-b5c5-57d43530a293
    [Document ID] => 1083813
    [Document naam] => RE: J&J Announces Topline Phase 3 Data for COVID-19 Vaccine
    [Bestandsnaam] => 
    [Beoordeling] => 
    [Beoordelingsgrond] => 
    [Toelichting] => 
    [Publieke link] => 
    [Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo/document/VWS-WOO-08-1083813
    [Opgeschort] => 
    [Definitief ID] => VWS-WOO-08-1083813
    [Status] => 
    [FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo
    [DocumentPublicationDate] => 31 januari 2021
    [DocumentStatusCheckedDate] => 
    [DocumentStatusCheckedResult] => 
    [SourceFileType] => 
    [Tags] => 
    [Besluit] => 
    [ModifiedDate] => 2025-09-21 17:19:13
    [DeletedDate] => 
    [BesluitURL] => 
    [CreatedDate] => 2025-06-19 18:31:59
    [DocumentDownloadLink] => 
    [DigestLaatsteControleDatum] => 2025-09-21 17:19:13
)

Document: VWS-WOO-08-1083813

Pagina 1 preview
Klik om te vergroten

Document correcties

Geregistreerde datum: 20210131

Geregistreerde documentnaam: RE: J&J Announces Topline Phase 3 Data for COVID-19 Vaccine

Document metadata

Metadata tonen (25 velden)
VeldWaarde
ide3f3badb-e662-4c6f-b5c5-57d43530a293
Document ID1083813
Document naamRE: J&J Announces Topline Phase 3 Data for COVID-19 Vaccine
Bestandsnaamleeg!
Beoordelingleeg!
Beoordelingsgrondleeg!
Toelichtingleeg!
Publieke linkleeg!
Locatie open.minvws.nlhttps://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo/document/VWS-WOO-08-1083813
Opgeschortleeg!
Definitief IDVWS-WOO-08-1083813
Statusleeg!
FromFilehttps://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo
DocumentPublicationDate31 januari 2021
DocumentStatusCheckedDateleeg!
DocumentStatusCheckedResultleeg!
SourceFileTypeleeg!
Tagsleeg!
Besluitleeg!
ModifiedDate2025-09-21 17:19:13
DeletedDateleeg!
BesluitURLleeg!
CreatedDate2025-06-19 18:31:59
DocumentDownloadLinkleeg!
DigestLaatsteControleDatum2025-09-21 17:19:13

🧙 User tags

Nog geen user tags

Document attributen

TagWaardeDatum
Request_Omvang publicatie_paginas15.3712025-10-24 17:12:05
About_Gelakte gegevens_linkhref_3mailto:DienstpostbusDatalekkenDoo@minvws.nl2025-10-24 17:12:05
Request_Omvang publicatie_linkname_1Inventarislijst2025-10-24 17:12:05
Request_Omvang publicatie_linkhref_1https://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo/file/download/inventory2025-10-24 17:12:05
About_Gelakte gegevens5.1.2a Internationale betrekkingen 5.1.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten2025-10-24 17:12:05
Request_Omvang publicatie15.371 documenten waarvan 7.083 openbaar gemaakt Inventarislijst2025-10-24 17:12:05
document_SectionDownloadButton12025-07-10 20:43:53
DocumentDownload_linknameDownload (pdf, 2.16 MB)2025-07-10 20:43:53
DocumentDownload_linkhrefhttps://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo/file/download/document/1ee694c2-5e08-674a-af69-b5de068c54982025-07-10 20:43:53
DocumentDownload_proposed_filename (lokale kopie)VWS-WOO-08-1083813.pdf2025-07-10 20:43:53
document_documentPublicationDate2021-01-312025-06-22 23:42:09
document_documentNumberVWS-WOO-08-10838132025-06-22 23:42:09
document_SectionHTMLDataDivs32025-06-22 23:42:09
document_SectionAbout12025-06-22 23:42:09
About_Datum document31 januari 20212025-06-22 23:42:09
About_Type bronbestandE-mailbericht, 4 pagina's2025-06-22 23:42:09
About_Type bronbestand_paginas42025-06-22 23:42:09
About_Download alsPDF (2.16 MB)2025-06-22 23:42:09
About_Documentnummer10838132025-06-22 23:42:09
About_BeoordelingGedeeltelijke openbaarmaking2025-06-22 23:42:09
About_Gelakte gegevens_linkhref_1https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk52025-06-22 23:42:09
About_Gelakte gegevens_linkname_15.1.2a Internationale betrekkingen2025-06-22 23:42:09
About_Gelakte gegevens_linkhref_2https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk52025-06-22 23:42:09
About_Gelakte gegevens_linkname_25.1.2e Eerbiediging van de persoonlijke levenssfeer2025-06-22 23:42:09
About_Gelakte gegevens_linkname_3Laat het ons weten2025-06-22 23:42:09
document_SectionRequest12025-06-22 23:42:09
Request_Onderdeel vanWoo-deelbesluit aangaande Vaccinaties en Medicatie over de periode januari 20212025-06-22 23:42:09
Request_Onderdeel van_linkhref_1https://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo2025-06-22 23:42:09
Request_Onderdeel van_linkname_1Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode januari 20212025-06-22 23:42:09
Request_Samenvatting verzoekDe minister van Volksgezondheid, Welzijn en Sport heeft op 19 december 2022 een besluit genomen op verzoeken in het kader van de Wet open overheid. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties en Medicatie over de periode januari 2021.2025-06-22 23:42:09
Request_PeriodeJanuari 20212025-06-22 23:42:09
document_SectionDownloadButton02025-06-22 23:42:09
Request_Datum besluit19 december 20222025-06-22 23:42:09
document_SectionHistory12025-06-22 23:42:09
Request_Type besluitWoo-besluit2025-06-22 23:42:09
About_Gelakte gegevens5.1.2a Internationale betrekkingen 5.1.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten.2025-06-22 23:42:09
About_Gelakte gegevens_linkhref_3mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over RE: J&J Announces Topline Phase 3 Data for COVID-19 Vaccine (documentnummer 1ee694c2-5e08-674a-af69-b5de068c5498)2025-06-22 23:42:09
Request_Omvang openbaarmaking15.371 documenten, 25.508 pagina's Inventarislijst2025-06-22 23:42:09
Request_Omvang openbaarmaking_documenten15.3712025-06-22 23:42:09
Request_Omvang openbaarmaking_paginas25.5082025-06-22 23:42:09
Request_Omvang openbaarmaking_linkhref_1https://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo/file/download/inventory2025-06-22 23:42:09
Request_Omvang openbaarmaking_linkname_1Inventarislijst2025-06-22 23:42:09
document_documentNameRE: J&J Announces Topline Phase 3 Data for COVID-19 Vaccine2025-06-22 23:42:09
document_documentTypeE-mailbericht2025-06-22 23:42:09
History Actie_3Opschorting opgeheven2025-06-21 04:01:17
History Datum_316 augustus 2024 13:522025-06-21 04:01:17
History Actie_2Bronbestand toegevoegd (pdf, 2.16 MB)2025-06-21 04:01:17
History Datum_216 augustus 2024 14:052025-06-21 04:01:17
History Actie_1Bronbestand vervangen (pdf, 2.16 MB)2025-06-21 04:01:17
History Datum_119 augustus 2024 12:122025-06-21 04:01:17

Archiefversies (7 rijen)

Archiefrij 1 — 2025-09-07 17:22:01
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-1083813.pdf
documentName: VWS-WOO-08-1083813.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 2262458
documentCompressRatio: 0
documentDateModified: 2025-09-07 17:22:01
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:22:01
lastSeen: 2025-09-07 17:22:01
text: 1083813 EEFO@its.jnj.com] ®SieLy BEKELE gt.com) @|TS.JNJ.com]; ) @minvws.nl] From: 5.1.2e Sent:Sun1/31/2021 5:46:26 PM Subject: RE: J&J Announces Topline Phase 3Data forCOVID-19 Vaccine Received:Sun 1/31/2021 5:46:26 PM Prima! Verzonden metBlackBerry Work (www blackberry com) Datum: zondag 31jan.202...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: f935b7403d80bf25b9a8499d6a4c5c3dd128546a4523037ef8ef5c915a0a06d6
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:10.664062+00
Id: folder_import_30082_28e01bece4c91c06d79e0ccedb1a6cd5
textDigestSHA256: 97def7877be9f3daa4929c29c24f33e4489ee84423733a907da5e5f1890efaa1
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1083813
Archiefrij 2 — 2025-09-04 17:03:04
fromFile: VWS-WOO-3477674-1040721-pdo-1f026c98-b466-6708-a84b-65673e0af118.zip
fromFilePath: ../../archieven_files/VWS-WOO-3477674-1040721-pdo-1f026c98-b466-6708-a84b-65673e0af118.zip
documentName: VWS-WOO-08-1083813.pdf
documentType: pdf
documentCompressedSize: 1732583
documentSize: 2262458
documentCompressRatio: 76.57967573320698
documentDateModified: 2025-05-01 20:46:00
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 17:03:04
lastSeen: 2025-09-04 17:03:04
text: 1083813 EEFO@its.jnj.com] ®SieLy BEKELE gt.com) @|TS.JNJ.com]; ) @minvws.nl] From: 5.1.2e Sent:Sun1/31/2021 5:46:26 PM Subject: RE: J&J Announces Topline Phase 3Data forCOVID-19 Vaccine Received:Sun 1/31/2021 5:46:26 PM Prima! Verzonden metBlackBerry Work (www blackberry com) Datum: zondag 31jan.202...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: f935b7403d80bf25b9a8499d6a4c5c3dd128546a4523037ef8ef5c915a0a06d6
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: VWS-WOO-3477674-1040721-pdo-1f026c98-b466-6708-a84b-65673e0af118.zip_4738
textDigestSHA256: 97def7877be9f3daa4929c29c24f33e4489ee84423733a907da5e5f1890efaa1
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1083813
Archiefrij 3 — 2025-03-18 09:30:25
fromFile: 2024.075-VWS-WOO-3477674-1040721-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2024.075-VWS-WOO-3477674-1040721-pdo.zip
documentName: VWS-WOO-08-1083813-RE_J_J_Announces_Topline_Phase_3_Data_for_COVID-19_Vaccine.pdf
documentType: pdf
documentCompressedSize: 1728877
documentSize: 2262458
documentCompressRatio: 76.41587158745047
documentDateModified: 2024-11-14 10:53:20
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-18 09:30:25
lastSeen: 2025-03-18 09:30:25
text: 1083813 EEFO@its.jnj.com] ®SieLy BEKELE gt.com) @|TS.JNJ.com]; ) @minvws.nl] From: 5.1.2e Sent:Sun1/31/2021 5:46:26 PM Subject: RE: J&J Announces Topline Phase 3Data forCOVID-19 Vaccine Received:Sun 1/31/2021 5:46:26 PM Prima! Verzonden metBlackBerry Work (www blackberry com) Datum: zondag 31jan.202...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 97def7877be9f3daa4929c29c24f33e4489ee84423733a907da5e5f1890efaa1
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 333208
textDigestSHA256: 97def7877be9f3daa4929c29c24f33e4489ee84423733a907da5e5f1890efaa1
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1083813
Archiefrij 4 — 2025-02-27 09:25:05
fromFile: 2023.057-VWS-WOO-3477674-1040721-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.057-VWS-WOO-3477674-1040721-pdo.zip
documentName: VWS-WOO-08-1083813-RE_J_J_Announces_Topline_Phase_3_Data_for_COVID-19_Vaccine.pdf
documentType: pdf
documentCompressedSize: 1728877
documentSize: 2262458
documentCompressRatio: 76.41587158745047
documentDateModified: 2024-11-14 10:53:20
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:05
lastSeen: 2025-02-27 09:25:05
text: 1083813 EEFO@its.jnj.com] ®SieLy BEKELE gt.com) @|TS.JNJ.com]; ) @minvws.nl] From: 5.1.2e Sent:Sun1/31/2021 5:46:26 PM Subject: RE: J&J Announces Topline Phase 3Data forCOVID-19 Vaccine Received:Sun 1/31/2021 5:46:26 PM Prima! Verzonden metBlackBerry Work (www blackberry com) Datum: zondag 31jan.202...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 8, "email": "EEFO@its.jnj.com", "context": "1083813 EEFO@its.jnj.com] \u00aeSieLy BEKELE gt.com)"}, {"position": 65, "email": "@minvws.nl", "context": "gt.com) @|TS.JNJ.com]; ) @minvws.nl] From: 5.1.2e Sent:Sun1/31/2021"}, {"position": 949, "email": "@its.jnj.com", "context": "+31 (0)7 EER @its.jnj.com ConfidentialityNotice: This e-mail"}, {"position": 1701, "email": "@its.jnj.com", "context": "ce.BETS JEREDN175INcon EEEaitsjncom>: <A)@its.jnj.com= Subject:RE: J&J Announces"}, {"position": 2159, "email": "@its.jnj.com", "context": "office: +31(0)71 BEE @its.jnj.com ConfidentialityNotice: This e-mail"}, {"position": 2886, "email": "@its.jnj.com", "context": "2021 17:51 JRDNL @its.jnj.com=> a1JNJcon;INEERECIN[xox]EREitsuicon:IEEE IEEE<BRFLN@its.jnj.com> Subject:"}, {"position": 2946, "email": "BRFLN@its.jnj.com", "context": "JRDNL @its.jnj.com=> a1JNJcon;INEERECIN[xox]EREitsuicon:IEEE IEEE<BRFLN@its.jnj.com> Subject: [EXTERNAL] RE:"}, {"position": 3722, "email": "EEE@itsjnj.com", "context": "8:33PM ITS .JNJ.com>>, EEE@itsjnj.com (@its jnj.com=>> Onderwerp:RE:"}, {"position": 5142, "email": "@its.jnj.com", "context": "1NcRFLS EEd wits jnj.com-]5.1.2e(@its.jnj.com> Confidentiality Notice: This"}, {"position": 5845, "email": "@its.jnj.com", "context": "2021 17:24 To:&FINE| @its.jnj.com=> Ce: 3ed]CRPR CRPE@ITSINJ.com>"}, {"position": 5873, "email": "CRPE@ITSINJ.com", "context": "@its.jnj.com=> Ce: 3ed]CRPR CRPE@ITSINJ.com> Subject: [EXTERNAL] RE:"}, {"position": 6311, "email": "NEXEM@itsjnj.com", "context": "twee doses? Groet Van:I'RDNL|EEE@itsjnjcom<NEXEM@itsjnj.com>> Verzonden: vrijdag29januari 2021"}, {"position": 6391, "email": "A@its.jnj.com", "context": "17:01 ITsNIcom>;INEEEEE XE <A@its.jnj.com<]A.@its jnj.com>> Onderwerp: J&J"}, {"position": 7447, "email": "@its.jnj.com", "context": "office: +31Qc BEd @its.jnj.com (@its.jnj.com> ConfidentialityNotice: This"}, {"position": 7461, "email": "@its.jnj.com", "context": "+31Qc BEd @its.jnj.com (@its.jnj.com> ConfidentialityNotice: This e-mail"}]
documentMailAdresses: [{"position": 8, "email": "EEFO@its.jnj.com", "context": "1083813 EEFO@its.jnj.com] \u00aeSieLy BEKELE gt.com)"}, {"position": 65, "email": "@minvws.nl", "context": "gt.com) @|TS.JNJ.com]; ) @minvws.nl] From: 5.1.2e Sent:Sun1/31/2021"}, {"position": 949, "email": "@its.jnj.com", "context": "+31 (0)7 EER @its.jnj.com ConfidentialityNotice: This e-mail"}, {"position": 1701, "email": "@its.jnj.com", "context": "ce.BETS JEREDN175INcon EEEaitsjncom>: <A)@its.jnj.com= Subject:RE: J&J Announces"}, {"position": 2159, "email": "@its.jnj.com", "context": "office: +31(0)71 BEE @its.jnj.com ConfidentialityNotice: This e-mail"}, {"position": 2886, "email": "@its.jnj.com", "context": "2021 17:51 JRDNL @its.jnj.com=> a1JNJcon;INEERECIN[xox]EREitsuicon:IEEE IEEE<BRFLN@its.jnj.com> Subject:"}, {"position": 2946, "email": "BRFLN@its.jnj.com", "context": "JRDNL @its.jnj.com=> a1JNJcon;INEERECIN[xox]EREitsuicon:IEEE IEEE<BRFLN@its.jnj.com> Subject: [EXTERNAL] RE:"}, {"position": 3722, "email": "EEE@itsjnj.com", "context": "8:33PM ITS .JNJ.com>>, EEE@itsjnj.com (@its jnj.com=>> Onderwerp:RE:"}, {"position": 5142, "email": "@its.jnj.com", "context": "1NcRFLS EEd wits jnj.com-]5.1.2e(@its.jnj.com> Confidentiality Notice: This"}, {"position": 5845, "email": "@its.jnj.com", "context": "2021 17:24 To:&FINE| @its.jnj.com=> Ce: 3ed]CRPR CRPE@ITSINJ.com>"}, {"position": 5873, "email": "CRPE@ITSINJ.com", "context": "@its.jnj.com=> Ce: 3ed]CRPR CRPE@ITSINJ.com> Subject: [EXTERNAL] RE:"}, {"position": 6311, "email": "NEXEM@itsjnj.com", "context": "twee doses? Groet Van:I'RDNL|EEE@itsjnjcom<NEXEM@itsjnj.com>> Verzonden: vrijdag29januari 2021"}, {"position": 6391, "email": "A@its.jnj.com", "context": "17:01 ITsNIcom>;INEEEEE XE <A@its.jnj.com<]A.@its jnj.com>> Onderwerp: J&J"}, {"position": 7447, "email": "@its.jnj.com", "context": "office: +31Qc BEd @its.jnj.com (@its.jnj.com> ConfidentialityNotice: This"}, {"position": 7461, "email": "@its.jnj.com", "context": "+31Qc BEd @its.jnj.com (@its.jnj.com> ConfidentialityNotice: This e-mail"}]
digestSHA256: 97def7877be9f3daa4929c29c24f33e4489ee84423733a907da5e5f1890efaa1
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 246296
textDigestSHA256: 97def7877be9f3daa4929c29c24f33e4489ee84423733a907da5e5f1890efaa1
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1083813
Archiefrij 5 — 2025-02-18 12:18:13
fromFile: Besluit__dossier_nr_-7b96e539f6d667469c9ac30d7d6532aa0289bb878a63cc17383edcca0c24d48d.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-7b96e539f6d667469c9ac30d7d6532aa0289bb878a63cc17383edcca0c24d48d.zip
documentName: VWS-WOO-08-1083813-RE_J_J_Announces_Topline_Phase_3_Data_for_COVID-19_Vaccine.pdf
documentType: pdf
documentCompressedSize: 1728877
documentSize: 2262458
documentCompressRatio: 76.41587158745047
documentDateModified: 2024-11-14 10:53:20
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:13
lastSeen: 2025-02-18 12:18:13
text: 1083813 EEFO@its.jnj.com] ®SieLy BEKELE gt.com) @|TS.JNJ.com]; ) @minvws.nl] From: 5.1.2e Sent:Sun1/31/2021 5:46:26 PM Subject: RE: J&J Announces Topline Phase 3Data forCOVID-19 Vaccine Received:Sun 1/31/2021 5:46:26 PM Prima! Verzonden metBlackBerry Work (www blackberry com) Datum: zondag 31jan.202...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 8, "email": "EEFO@its.jnj.com", "context": "1083813 EEFO@its.jnj.com] \u00aeSieLy BEKELE gt.com)"}, {"position": 65, "email": "@minvws.nl", "context": "gt.com) @|TS.JNJ.com]; ) @minvws.nl] From: 5.1.2e Sent:Sun1/31/2021"}, {"position": 949, "email": "@its.jnj.com", "context": "+31 (0)7 EER @its.jnj.com ConfidentialityNotice: This e-mail"}, {"position": 1701, "email": "@its.jnj.com", "context": "ce.BETS JEREDN175INcon EEEaitsjncom>: <A)@its.jnj.com= Subject:RE: J&J Announces"}, {"position": 2159, "email": "@its.jnj.com", "context": "office: +31(0)71 BEE @its.jnj.com ConfidentialityNotice: This e-mail"}, {"position": 2886, "email": "@its.jnj.com", "context": "2021 17:51 JRDNL @its.jnj.com=> a1JNJcon;INEERECIN[xox]EREitsuicon:IEEE IEEE<BRFLN@its.jnj.com> Subject:"}, {"position": 2946, "email": "BRFLN@its.jnj.com", "context": "JRDNL @its.jnj.com=> a1JNJcon;INEERECIN[xox]EREitsuicon:IEEE IEEE<BRFLN@its.jnj.com> Subject: [EXTERNAL] RE:"}, {"position": 3722, "email": "EEE@itsjnj.com", "context": "8:33PM ITS .JNJ.com>>, EEE@itsjnj.com (@its jnj.com=>> Onderwerp:RE:"}, {"position": 5142, "email": "@its.jnj.com", "context": "1NcRFLS EEd wits jnj.com-]5.1.2e(@its.jnj.com> Confidentiality Notice: This"}, {"position": 5845, "email": "@its.jnj.com", "context": "2021 17:24 To:&FINE| @its.jnj.com=> Ce: 3ed]CRPR CRPE@ITSINJ.com>"}, {"position": 5873, "email": "CRPE@ITSINJ.com", "context": "@its.jnj.com=> Ce: 3ed]CRPR CRPE@ITSINJ.com> Subject: [EXTERNAL] RE:"}, {"position": 6311, "email": "NEXEM@itsjnj.com", "context": "twee doses? Groet Van:I'RDNL|EEE@itsjnjcom<NEXEM@itsjnj.com>> Verzonden: vrijdag29januari 2021"}, {"position": 6391, "email": "A@its.jnj.com", "context": "17:01 ITsNIcom>;INEEEEE XE <A@its.jnj.com<]A.@its jnj.com>> Onderwerp: J&J"}, {"position": 7447, "email": "@its.jnj.com", "context": "office: +31Qc BEd @its.jnj.com (@its.jnj.com> ConfidentialityNotice: This"}, {"position": 7461, "email": "@its.jnj.com", "context": "+31Qc BEd @its.jnj.com (@its.jnj.com> ConfidentialityNotice: This e-mail"}]
documentMailAdresses: [{"position": 8, "email": "EEFO@its.jnj.com", "context": "1083813 EEFO@its.jnj.com] \u00aeSieLy BEKELE gt.com)"}, {"position": 65, "email": "@minvws.nl", "context": "gt.com) @|TS.JNJ.com]; ) @minvws.nl] From: 5.1.2e Sent:Sun1/31/2021"}, {"position": 949, "email": "@its.jnj.com", "context": "+31 (0)7 EER @its.jnj.com ConfidentialityNotice: This e-mail"}, {"position": 1701, "email": "@its.jnj.com", "context": "ce.BETS JEREDN175INcon EEEaitsjncom>: <A)@its.jnj.com= Subject:RE: J&J Announces"}, {"position": 2159, "email": "@its.jnj.com", "context": "office: +31(0)71 BEE @its.jnj.com ConfidentialityNotice: This e-mail"}, {"position": 2886, "email": "@its.jnj.com", "context": "2021 17:51 JRDNL @its.jnj.com=> a1JNJcon;INEERECIN[xox]EREitsuicon:IEEE IEEE<BRFLN@its.jnj.com> Subject:"}, {"position": 2946, "email": "BRFLN@its.jnj.com", "context": "JRDNL @its.jnj.com=> a1JNJcon;INEERECIN[xox]EREitsuicon:IEEE IEEE<BRFLN@its.jnj.com> Subject: [EXTERNAL] RE:"}, {"position": 3722, "email": "EEE@itsjnj.com", "context": "8:33PM ITS .JNJ.com>>, EEE@itsjnj.com (@its jnj.com=>> Onderwerp:RE:"}, {"position": 5142, "email": "@its.jnj.com", "context": "1NcRFLS EEd wits jnj.com-]5.1.2e(@its.jnj.com> Confidentiality Notice: This"}, {"position": 5845, "email": "@its.jnj.com", "context": "2021 17:24 To:&FINE| @its.jnj.com=> Ce: 3ed]CRPR CRPE@ITSINJ.com>"}, {"position": 5873, "email": "CRPE@ITSINJ.com", "context": "@its.jnj.com=> Ce: 3ed]CRPR CRPE@ITSINJ.com> Subject: [EXTERNAL] RE:"}, {"position": 6311, "email": "NEXEM@itsjnj.com", "context": "twee doses? Groet Van:I'RDNL|EEE@itsjnjcom<NEXEM@itsjnj.com>> Verzonden: vrijdag29januari 2021"}, {"position": 6391, "email": "A@its.jnj.com", "context": "17:01 ITsNIcom>;INEEEEE XE <A@its.jnj.com<]A.@its jnj.com>> Onderwerp: J&J"}, {"position": 7447, "email": "@its.jnj.com", "context": "office: +31Qc BEd @its.jnj.com (@its.jnj.com> ConfidentialityNotice: This"}, {"position": 7461, "email": "@its.jnj.com", "context": "+31Qc BEd @its.jnj.com (@its.jnj.com> ConfidentialityNotice: This e-mail"}]
digestSHA256: 97def7877be9f3daa4929c29c24f33e4489ee84423733a907da5e5f1890efaa1
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 115920
textDigestSHA256: 97def7877be9f3daa4929c29c24f33e4489ee84423733a907da5e5f1890efaa1
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1083813
Archiefrij 6 — 2025-02-18 12:18:04
fromFile: Besluit__dossier_nr_-56dedcf3b5a6fd477519d5eceba72bb3d95085d3ef569f0f6cb8c5110cd5ac60.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-56dedcf3b5a6fd477519d5eceba72bb3d95085d3ef569f0f6cb8c5110cd5ac60.zip
documentName: VWS-WOO-08-1083813-RE_J_J_Announces_Topline_Phase_3_Data_for_COVID-19_Vaccine.pdf
documentType: pdf
documentCompressedSize: 1728877
documentSize: 2262458
documentCompressRatio: 76.41587158745047
documentDateModified: 2024-10-31 16:07:04
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:04
lastSeen: 2025-02-18 12:18:04
text: 1083813 EEFO@its.jnj.com] ®SieLy BEKELE gt.com) @|TS.JNJ.com]; ) @minvws.nl] From: 5.1.2e Sent:Sun1/31/2021 5:46:26 PM Subject: RE: J&J Announces Topline Phase 3Data forCOVID-19 Vaccine Received:Sun 1/31/2021 5:46:26 PM Prima! Verzonden metBlackBerry Work (www blackberry com) Datum: zondag 31jan.202...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 8, "email": "EEFO@its.jnj.com", "context": "1083813 EEFO@its.jnj.com] \u00aeSieLy BEKELE gt.com)"}, {"position": 65, "email": "@minvws.nl", "context": "gt.com) @|TS.JNJ.com]; ) @minvws.nl] From: 5.1.2e Sent:Sun1/31/2021"}, {"position": 949, "email": "@its.jnj.com", "context": "+31 (0)7 EER @its.jnj.com ConfidentialityNotice: This e-mail"}, {"position": 1701, "email": "@its.jnj.com", "context": "ce.BETS JEREDN175INcon EEEaitsjncom>: <A)@its.jnj.com= Subject:RE: J&J Announces"}, {"position": 2159, "email": "@its.jnj.com", "context": "office: +31(0)71 BEE @its.jnj.com ConfidentialityNotice: This e-mail"}, {"position": 2886, "email": "@its.jnj.com", "context": "2021 17:51 JRDNL @its.jnj.com=> a1JNJcon;INEERECIN[xox]EREitsuicon:IEEE IEEE<BRFLN@its.jnj.com> Subject:"}, {"position": 2946, "email": "BRFLN@its.jnj.com", "context": "JRDNL @its.jnj.com=> a1JNJcon;INEERECIN[xox]EREitsuicon:IEEE IEEE<BRFLN@its.jnj.com> Subject: [EXTERNAL] RE:"}, {"position": 3722, "email": "EEE@itsjnj.com", "context": "8:33PM ITS .JNJ.com>>, EEE@itsjnj.com (@its jnj.com=>> Onderwerp:RE:"}, {"position": 5142, "email": "@its.jnj.com", "context": "1NcRFLS EEd wits jnj.com-]5.1.2e(@its.jnj.com> Confidentiality Notice: This"}, {"position": 5845, "email": "@its.jnj.com", "context": "2021 17:24 To:&FINE| @its.jnj.com=> Ce: 3ed]CRPR CRPE@ITSINJ.com>"}, {"position": 5873, "email": "CRPE@ITSINJ.com", "context": "@its.jnj.com=> Ce: 3ed]CRPR CRPE@ITSINJ.com> Subject: [EXTERNAL] RE:"}, {"position": 6311, "email": "NEXEM@itsjnj.com", "context": "twee doses? Groet Van:I'RDNL|EEE@itsjnjcom<NEXEM@itsjnj.com>> Verzonden: vrijdag29januari 2021"}, {"position": 6391, "email": "A@its.jnj.com", "context": "17:01 ITsNIcom>;INEEEEE XE <A@its.jnj.com<]A.@its jnj.com>> Onderwerp: J&J"}, {"position": 7447, "email": "@its.jnj.com", "context": "office: +31Qc BEd @its.jnj.com (@its.jnj.com> ConfidentialityNotice: This"}, {"position": 7461, "email": "@its.jnj.com", "context": "+31Qc BEd @its.jnj.com (@its.jnj.com> ConfidentialityNotice: This e-mail"}]
documentMailAdresses: [{"position": 8, "email": "EEFO@its.jnj.com", "context": "1083813 EEFO@its.jnj.com] \u00aeSieLy BEKELE gt.com)"}, {"position": 65, "email": "@minvws.nl", "context": "gt.com) @|TS.JNJ.com]; ) @minvws.nl] From: 5.1.2e Sent:Sun1/31/2021"}, {"position": 949, "email": "@its.jnj.com", "context": "+31 (0)7 EER @its.jnj.com ConfidentialityNotice: This e-mail"}, {"position": 1701, "email": "@its.jnj.com", "context": "ce.BETS JEREDN175INcon EEEaitsjncom>: <A)@its.jnj.com= Subject:RE: J&J Announces"}, {"position": 2159, "email": "@its.jnj.com", "context": "office: +31(0)71 BEE @its.jnj.com ConfidentialityNotice: This e-mail"}, {"position": 2886, "email": "@its.jnj.com", "context": "2021 17:51 JRDNL @its.jnj.com=> a1JNJcon;INEERECIN[xox]EREitsuicon:IEEE IEEE<BRFLN@its.jnj.com> Subject:"}, {"position": 2946, "email": "BRFLN@its.jnj.com", "context": "JRDNL @its.jnj.com=> a1JNJcon;INEERECIN[xox]EREitsuicon:IEEE IEEE<BRFLN@its.jnj.com> Subject: [EXTERNAL] RE:"}, {"position": 3722, "email": "EEE@itsjnj.com", "context": "8:33PM ITS .JNJ.com>>, EEE@itsjnj.com (@its jnj.com=>> Onderwerp:RE:"}, {"position": 5142, "email": "@its.jnj.com", "context": "1NcRFLS EEd wits jnj.com-]5.1.2e(@its.jnj.com> Confidentiality Notice: This"}, {"position": 5845, "email": "@its.jnj.com", "context": "2021 17:24 To:&FINE| @its.jnj.com=> Ce: 3ed]CRPR CRPE@ITSINJ.com>"}, {"position": 5873, "email": "CRPE@ITSINJ.com", "context": "@its.jnj.com=> Ce: 3ed]CRPR CRPE@ITSINJ.com> Subject: [EXTERNAL] RE:"}, {"position": 6311, "email": "NEXEM@itsjnj.com", "context": "twee doses? Groet Van:I'RDNL|EEE@itsjnjcom<NEXEM@itsjnj.com>> Verzonden: vrijdag29januari 2021"}, {"position": 6391, "email": "A@its.jnj.com", "context": "17:01 ITsNIcom>;INEEEEE XE <A@its.jnj.com<]A.@its jnj.com>> Onderwerp: J&J"}, {"position": 7447, "email": "@its.jnj.com", "context": "office: +31Qc BEd @its.jnj.com (@its.jnj.com> ConfidentialityNotice: This"}, {"position": 7461, "email": "@its.jnj.com", "context": "+31Qc BEd @its.jnj.com (@its.jnj.com> ConfidentialityNotice: This e-mail"}]
digestSHA256: 97def7877be9f3daa4929c29c24f33e4489ee84423733a907da5e5f1890efaa1
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 69587
textDigestSHA256: 97def7877be9f3daa4929c29c24f33e4489ee84423733a907da5e5f1890efaa1
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1083813
Archiefrij 7 — 2025-02-18 12:17:59
fromFile: Besluit__dossier_nr_-571f1ae5b0d04da300d026d2496e833b604aa1615f95ba2726b608e5251d62aa.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-571f1ae5b0d04da300d026d2496e833b604aa1615f95ba2726b608e5251d62aa.zip
documentName: VWS-WOO-08-1083813-RE_J_J_Announces_Topline_Phase_3_Data_for_COVID-19_Vaccine.pdf
documentType: pdf
documentCompressedSize: 1728877
documentSize: 2262458
documentCompressRatio: 76.41587158745047
documentDateModified: 2024-08-19 14:21:38
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:17:59
lastSeen: 2025-02-18 12:17:59
text: 1083813 EEFO@its.jnj.com] ®SieLy BEKELE gt.com) @|TS.JNJ.com]; ) @minvws.nl] From: 5.1.2e Sent:Sun1/31/2021 5:46:26 PM Subject: RE: J&J Announces Topline Phase 3Data forCOVID-19 Vaccine Received:Sun 1/31/2021 5:46:26 PM Prima! Verzonden metBlackBerry Work (www blackberry com) Datum: zondag 31jan.202...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 8, "email": "EEFO@its.jnj.com", "context": "1083813 EEFO@its.jnj.com] \u00aeSieLy BEKELE gt.com)"}, {"position": 65, "email": "@minvws.nl", "context": "gt.com) @|TS.JNJ.com]; ) @minvws.nl] From: 5.1.2e Sent:Sun1/31/2021"}, {"position": 949, "email": "@its.jnj.com", "context": "+31 (0)7 EER @its.jnj.com ConfidentialityNotice: This e-mail"}, {"position": 1701, "email": "@its.jnj.com", "context": "ce.BETS JEREDN175INcon EEEaitsjncom>: <A)@its.jnj.com= Subject:RE: J&J Announces"}, {"position": 2159, "email": "@its.jnj.com", "context": "office: +31(0)71 BEE @its.jnj.com ConfidentialityNotice: This e-mail"}, {"position": 2886, "email": "@its.jnj.com", "context": "2021 17:51 JRDNL @its.jnj.com=> a1JNJcon;INEERECIN[xox]EREitsuicon:IEEE IEEE<BRFLN@its.jnj.com> Subject:"}, {"position": 2946, "email": "BRFLN@its.jnj.com", "context": "JRDNL @its.jnj.com=> a1JNJcon;INEERECIN[xox]EREitsuicon:IEEE IEEE<BRFLN@its.jnj.com> Subject: [EXTERNAL] RE:"}, {"position": 3722, "email": "EEE@itsjnj.com", "context": "8:33PM ITS .JNJ.com>>, EEE@itsjnj.com (@its jnj.com=>> Onderwerp:RE:"}, {"position": 5142, "email": "@its.jnj.com", "context": "1NcRFLS EEd wits jnj.com-]5.1.2e(@its.jnj.com> Confidentiality Notice: This"}, {"position": 5845, "email": "@its.jnj.com", "context": "2021 17:24 To:&FINE| @its.jnj.com=> Ce: 3ed]CRPR CRPE@ITSINJ.com>"}, {"position": 5873, "email": "CRPE@ITSINJ.com", "context": "@its.jnj.com=> Ce: 3ed]CRPR CRPE@ITSINJ.com> Subject: [EXTERNAL] RE:"}, {"position": 6311, "email": "NEXEM@itsjnj.com", "context": "twee doses? Groet Van:I'RDNL|EEE@itsjnjcom<NEXEM@itsjnj.com>> Verzonden: vrijdag29januari 2021"}, {"position": 6391, "email": "A@its.jnj.com", "context": "17:01 ITsNIcom>;INEEEEE XE <A@its.jnj.com<]A.@its jnj.com>> Onderwerp: J&J"}, {"position": 7447, "email": "@its.jnj.com", "context": "office: +31Qc BEd @its.jnj.com (@its.jnj.com> ConfidentialityNotice: This"}, {"position": 7461, "email": "@its.jnj.com", "context": "+31Qc BEd @its.jnj.com (@its.jnj.com> ConfidentialityNotice: This e-mail"}]
documentMailAdresses: [{"position": 8, "email": "EEFO@its.jnj.com", "context": "1083813 EEFO@its.jnj.com] \u00aeSieLy BEKELE gt.com)"}, {"position": 65, "email": "@minvws.nl", "context": "gt.com) @|TS.JNJ.com]; ) @minvws.nl] From: 5.1.2e Sent:Sun1/31/2021"}, {"position": 949, "email": "@its.jnj.com", "context": "+31 (0)7 EER @its.jnj.com ConfidentialityNotice: This e-mail"}, {"position": 1701, "email": "@its.jnj.com", "context": "ce.BETS JEREDN175INcon EEEaitsjncom>: <A)@its.jnj.com= Subject:RE: J&J Announces"}, {"position": 2159, "email": "@its.jnj.com", "context": "office: +31(0)71 BEE @its.jnj.com ConfidentialityNotice: This e-mail"}, {"position": 2886, "email": "@its.jnj.com", "context": "2021 17:51 JRDNL @its.jnj.com=> a1JNJcon;INEERECIN[xox]EREitsuicon:IEEE IEEE<BRFLN@its.jnj.com> Subject:"}, {"position": 2946, "email": "BRFLN@its.jnj.com", "context": "JRDNL @its.jnj.com=> a1JNJcon;INEERECIN[xox]EREitsuicon:IEEE IEEE<BRFLN@its.jnj.com> Subject: [EXTERNAL] RE:"}, {"position": 3722, "email": "EEE@itsjnj.com", "context": "8:33PM ITS .JNJ.com>>, EEE@itsjnj.com (@its jnj.com=>> Onderwerp:RE:"}, {"position": 5142, "email": "@its.jnj.com", "context": "1NcRFLS EEd wits jnj.com-]5.1.2e(@its.jnj.com> Confidentiality Notice: This"}, {"position": 5845, "email": "@its.jnj.com", "context": "2021 17:24 To:&FINE| @its.jnj.com=> Ce: 3ed]CRPR CRPE@ITSINJ.com>"}, {"position": 5873, "email": "CRPE@ITSINJ.com", "context": "@its.jnj.com=> Ce: 3ed]CRPR CRPE@ITSINJ.com> Subject: [EXTERNAL] RE:"}, {"position": 6311, "email": "NEXEM@itsjnj.com", "context": "twee doses? Groet Van:I'RDNL|EEE@itsjnjcom<NEXEM@itsjnj.com>> Verzonden: vrijdag29januari 2021"}, {"position": 6391, "email": "A@its.jnj.com", "context": "17:01 ITsNIcom>;INEEEEE XE <A@its.jnj.com<]A.@its jnj.com>> Onderwerp: J&J"}, {"position": 7447, "email": "@its.jnj.com", "context": "office: +31Qc BEd @its.jnj.com (@its.jnj.com> ConfidentialityNotice: This"}, {"position": 7461, "email": "@its.jnj.com", "context": "+31Qc BEd @its.jnj.com (@its.jnj.com> ConfidentialityNotice: This e-mail"}]
digestSHA256: 97def7877be9f3daa4929c29c24f33e4489ee84423733a907da5e5f1890efaa1
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 9641
textDigestSHA256: 97def7877be9f3daa4929c29c24f33e4489ee84423733a907da5e5f1890efaa1
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1083813
Nieuw document zoeken

(dit is ook een speeltuin)